Chronic sinusitis responds best to a layered approach rather than any single treatment. The foundation that works for most people is straightforward: daily high-volume saline nasal irrigation combined with an intranasal corticosteroid spray. From there, effective treatment depends heavily on what type of chronic sinusitis you have, whether nasal polyps are involved, and how your body’s inflammation behaves at a cellular level. That distinction matters more than most patients realize, because it determines whether you’ll do well with sprays alone, need a biologic drug, or benefit most from surgery.
The Two Treatments Nearly Everyone Should Be Doing
If you take away one thing from this article, it’s this: saline irrigation and intranasal corticosteroid sprays are the bedrock of chronic sinusitis management. They’re recommended by every major guideline, they’re safe for long-term use, and they’re the treatments with the broadest evidence base. High-volume, low-pressure saline rinses (think squeeze bottle or neti pot, not a gentle mist) are the most efficient method for physically clearing out mucus, allergens, bacteria, and inflammatory debris from the sinuses.1PubMed Central. Nasal Irrigations: A 360-Degree View in Clinical Practice The emphasis on “high-volume” is deliberate. A quick spritz from a saline spray can moisturize the nasal lining, but it doesn’t flush the sinuses the way a full 240 mL rinse does.
Intranasal corticosteroid sprays (like fluticasone, mometasone, or budesonide) tackle the inflammation that keeps sinuses swollen and blocked. High-level evidence and position papers support their role in chronic sinusitis treatment, with improvements in both disease-specific and general quality-of-life measures across all formulations.2PubMed. A Scholarly Review of the Safety and Efficacy of Intranasal Corticosteroids Preparations in the Treatment of Chronic Rhinosinusitis A meta-analysis of safety data found that the main side effect was an increased risk of nosebleeds compared to placebo, with no other significant differences.3PubMed. Intranasal Corticosteroid Therapy: Systematic Review and Meta-analysis of Reported Safety and Adverse Effects in Adults That’s a reassuring profile for something many people will use for months or years. The key is consistency: these sprays reduce inflammation gradually and need to be used daily, not just when symptoms flare.
Some doctors prescribe budesonide mixed into saline rinses rather than used as a standard spray, aiming to get the steroid deeper into the sinuses. This off-label approach has become common in specialty clinics, though the safety data for non-standard delivery methods is more limited than for conventional sprays.
Why Chronic Sinusitis Is Not One Disease
One of the biggest shifts in how specialists think about chronic sinusitis is the recognition that it’s not a single condition. It’s a group of diseases that all happen to produce similar symptoms: congestion, facial pressure, thick drainage, and reduced sense of smell. Under the surface, the inflammatory patterns can be completely different from one person to the next. Chronic sinusitis is increasingly understood as a heterogeneous condition with distinct inflammatory subtypes. In Western populations, the inflammation is mostly driven by a type 2 (eosinophilic) immune response, which is the kind associated with allergies, asthma, and nasal polyps. But in Asian populations, non-type-2 patterns are much more common, which limits how well Western treatment models apply globally.4Sinusitis. Clinical Significance of Endotypes of Asian Chronic Rhinosinusitis: A Review and Expert Commentary
This matters for treatment because therapies that work well for type 2 inflammation (steroids, biologics) are less effective for non-type-2 disease. If you’ve been doing everything “right” and your sinuses aren’t improving, the type of inflammation you have could be the reason. Bacterial biofilms also play a role in why some cases resist treatment. Patients with biofilm-forming bacteria in their sinuses tend to have worse imaging scores before surgery and are more likely to have ongoing symptoms afterward.5PubMed Central. Biofilms in chronic rhinosinusitis: Pathophysiology and therapeutic strategies Biofilms are essentially bacterial colonies wrapped in a protective slime that antibiotics can’t easily penetrate, which helps explain why repeated courses of antibiotics often fail to cure chronic sinusitis.
Short Courses of Oral Steroids
When intranasal steroids alone aren’t enough, doctors sometimes prescribe a short burst of oral prednisone or prednisolone, typically lasting two to three weeks. For patients with nasal polyps, a Cochrane review found that oral steroids improved quality of life and reduced symptom severity by the end of the treatment course. But the benefit faded: at three to six months after stopping, there was little or no difference in quality of life or symptoms compared to people who took a placebo.6PubMed Central. Short‐course oral steroids alone for chronic rhinosinusitis The quality of the evidence behind that short-term benefit was rated low, which means the true effect could be smaller or larger than observed.
Interestingly, oral steroids may be more durably useful for chronic sinusitis without nasal polyps. In one trial, about half of patients treated with a short course of prednisolone had improved symptoms and did not need sinus surgery at 12 months, compared to roughly one in seven in the control group.7PubMed. Short-term Oral Steroids Significantly Improves Chronic Rhinosinusitis Without Nasal Polyps That’s a single study, so the numbers deserve caution, but it suggests that a well-timed steroid burst can sometimes reset inflammation enough to keep symptoms at bay. The catch is that repeated courses of oral steroids carry real risks: weight gain, bone thinning, elevated blood sugar, mood changes. Most specialists reserve oral steroids for specific flares or as a bridge before surgery, not as an ongoing treatment.
Low-Dose, Long-Term Macrolide Antibiotics
If your sinusitis is the non-type-2 variety (often characterized by neutrophilic rather than eosinophilic inflammation, and typically without prominent polyps), a completely different medication class enters the picture. Low-dose, long-term macrolide antibiotics like azithromycin or clarithromycin, taken for weeks to months at sub-antimicrobial doses, are used not to kill bacteria but for their anti-inflammatory properties. These drugs are generally believed to act specifically on non-type-2 inflammatory pathways.8PubMed Central. The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis This is an important distinction: macrolides are not a broad recommendation for all chronic sinusitis patients. They tend to help the subset whose inflammation doesn’t respond well to steroids. Your doctor can often get a sense of your inflammatory profile through blood eosinophil counts and nasal endoscopy findings.
Biologics for Severe Nasal Polyps
For people with chronic sinusitis with nasal polyps that keep coming back despite surgery and steroids, biologic drugs have been genuinely transformative. Dupilumab, which blocks two key inflammatory signals (interleukin-4 and interleukin-13), is the most studied and widely used. The treatment effect is fast: in pooled trial data, patients experienced significant improvements in sense of smell, nasal congestion, and total symptom scores within the first two to four days of starting treatment.9PubMed Central. Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps Those improvements continued and were sustained through the end of the treatment period.
Longer-term real-world data backs this up. One study following patients for 12 months found dramatic reductions in polyp size, symptom severity scores, and quality-of-life measures regardless of whether patients had previously tried other biologic drugs.10PubMed Central. Efficacy of dupilumab on chronic rhinosinusitis with nasal polyps and concomitant asthma in biologic-naive and biologic-pretreated patients Since asthma and nasal polyps share the same type 2 inflammatory pathway, dupilumab also improved lung function and asthma control in patients who had both conditions.11World Allergy Organization Journal. Long-term effects of dupilumab on chronic rhinosinusitis with nasal polyps: A step towards clinical remission Clinical remission (defined as near-complete resolution of disease) was achieved in about 11% of patients overall, with a slightly lower rate in those with asthma.
The limitations are real, though. Dupilumab requires ongoing subcutaneous injections (typically every two weeks), it costs thousands of dollars per month without insurance coverage, and it works specifically on type 2 inflammation. If your polyps aren’t driven by that pathway, you’re unlikely to respond. Other biologics targeting different inflammatory molecules (omalizumab, mepolizumab) are also approved or in trials for nasal polyps, expanding options for patients who don’t respond to dupilumab.
When Surgery Makes Sense
Functional endoscopic sinus surgery (FESS) remains the standard surgical approach when medical therapy fails. The procedure opens blocked sinus drainage pathways and removes diseased tissue, including polyps. A large randomized trial comparing surgery plus medical therapy against medical therapy alone in patients with nasal polyps found that surgery provided a statistically greater improvement in quality-of-life scores at 12 months, though the difference did not meet the threshold considered the minimum clinically important difference.12PubMed. Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial That finding sounds underwhelming, but context matters: the “medical therapy alone” group in that trial received aggressive treatment including oral steroids, and surgery’s benefits are often most pronounced in the domains patients care about most. A separate study found that the biggest quality-of-life gains after surgery were in nasal and smell-related symptoms, with somewhat smaller improvements in sleep and psychological functioning.13PubMed Central. SNOT-22 quality of life domains differentially predict treatment modality selection in chronic rhinosinusitis
Surgery is not a cure. It creates better anatomy for drainage and medication delivery, but the underlying inflammatory disease remains. Most patients still need ongoing medical therapy after surgery to maintain results. Revision surgery rates vary, but recurrence is common in patients with type 2 eosinophilic disease, which is one reason biologics have become an important alternative or complement to repeat operations.
Balloon Sinuplasty
Balloon sinuplasty uses an inflatable catheter to widen sinus openings without removing tissue. It’s less invasive than conventional FESS, with less bleeding and a shorter procedure time.14PubMed Central. To Determine the Efficacy of Balloon Sinuplasty over Conventional Functional Endoscopic Sinus Surgery A meta-analysis comparing the two approaches found no clinically meaningful difference in symptom outcomes.15PubMed Central. Balloon Sinus Dilation Versus Functional Endoscopic Sinus Surgery for Chronic Rhinosinusitis: Systematic Review and Meta-Analysis Balloon sinuplasty works best for straightforward cases involving blocked sinus openings without extensive polyp disease or complex anatomy. If polyps need to be removed or multiple sinuses are involved, conventional FESS is typically the better tool.
Steroid-Eluting Stents
After sinus surgery, scar tissue and recurrent polyps can narrow the openings that were just created. Steroid-eluting stents are small implants placed in the sinus opening during or after surgery that slowly release corticosteroid directly where it’s needed. A meta-analysis of these devices found they reduced rates of postoperative intervention, recurrent polyposis, and inflammation while helping keep sinus openings patent.16PubMed Central. Efficacy of steroid-eluting stents in management of chronic rhinosinusitis after endoscopic sinus surgery: updated meta-analysis A multisite trial of one such implant found minimal inflammation scores at all follow-up visits, with low rates of concerning complications like adhesion formation.17PubMed. ADVANCE: a multisite trial of bioabsorbable steroid-eluting sinus implants These devices are becoming a standard part of postoperative care in many practices.
Aspirin-Exacerbated Respiratory Disease
A subset of chronic sinusitis patients have a condition sometimes called Samter’s triad: nasal polyps, asthma, and reactions to aspirin or other NSAIDs like ibuprofen. This group tends to have particularly aggressive polyp regrowth after surgery and often needs multiple revision procedures. Aspirin desensitization, a process where gradually increasing doses of aspirin are given under medical supervision until the patient can tolerate a full dose, has become a well-established treatment for this specific population.18PubMed Central. Samter’s Triad: State of the Art Once desensitized, patients take daily high-dose aspirin to modulate the inflammatory cascade that drives their disease.19Current Treatment Options in Allergy. Aspirin Desensitization in Treatment of Chronic Rhinosinusitis with Nasal Polyposis: Current Protocols and Evidence
Long-term follow-up data suggests this approach is safe and effective even after more than 10 years of continuous use.20PubMed. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease If you have recurrent polyps and also react badly to ibuprofen or aspirin, this is worth bringing up with your doctor, as it’s often underutilized outside of specialty centers.
Treatments That Don’t Work
Not everything sold or prescribed for chronic sinusitis has evidence behind it. Antifungal treatments, both topical nasal rinses and oral pills, have been tested repeatedly and found wanting. A randomized trial of intranasal fluconazole showed no significant differences in symptom scores, endoscopic findings, or CT imaging compared to placebo after eight weeks.21PubMed Central. Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole A Cochrane meta-analysis pooling data across multiple trials found no benefit from either topical or systemic antifungals for any outcome measure. Symptom scores actually favored the placebo group, and adverse events were more common in the antifungal group.22Cochrane Database of Systematic Reviews. Antifungal therapy for chronic rhinosinusitis Despite this, the idea that fungi cause chronic sinusitis persists in some alternative medicine circles. The evidence clearly says otherwise.
Leukotriene receptor antagonists like montelukast occupy a murkier space. When added to an intranasal corticosteroid spray in patients with polyps after surgery, montelukast provided no additional benefit over the spray alone at any time point through one year of follow-up.23PubMed. Lack of long-term add-on effect by montelukast in postoperative chronic rhinosinusitis patients with nasal polyps However, a small study of patients with both polyps and asthma who were not post-surgical found that combining an intranasal corticosteroid with montelukast over 12 months significantly reduced polyp size and blood eosinophil counts.24Journal of Nippon Medical School. One-Year Evaluation of Combined Treatment with an Intranasal Corticosteroid and Montelukast for Chronic Rhinosinusitis Associated with Asthma The take-home: montelukast probably doesn’t add much for most patients already on intranasal steroids, but it might have a narrow role in the asthma-plus-polyps population before surgery. Given its mild side-effect profile, some doctors will try it in that specific group.
Getting Your Sense of Smell Back
Loss of smell is one of the most distressing symptoms of chronic sinusitis, and it’s often the slowest to recover even after successful treatment. Olfactory training, the practice of deliberately sniffing a set of strong scents (rose, eucalyptus, lemon, and clove are the classic four) twice daily for months, has real evidence behind it. After sinus surgery, patients who did early olfactory training had significantly better smell detection and discrimination scores at one, two, and three months compared to those who didn’t train.25PubMed Central. Effect of early olfactory training on olfactory recovery after nasal endoscopy in patients with chronic rhinosinusitis and olfactory impairment
Combining olfactory training with steroid rinses appears to be better than either alone. In a study of 133 patients with smell loss, about 44% of those who did budesonide irrigation plus olfactory training had clinically meaningful improvement, compared to 27% of those who did saline irrigation plus olfactory training.26PubMed. Budesonide irrigation with olfactory training improves outcomes compared with olfactory training alone in patients with olfactory loss Younger age and a shorter duration of smell loss were also significant predictors of recovery. A randomized trial comparing glucocorticoid treatment, olfactory training, and the combination after surgery found that the combined approach was superior at one month, though by six months the differences between groups narrowed.27PubMed. Chronic Sinusitis With Nasal Polyps and Olfactory Dysfunction: Comparing Olfactory Training and Glucocorticoid Treatment
The practical advice is clear: if your sense of smell hasn’t bounced back after surgery or medical treatment, start olfactory training early and combine it with topical steroid rinses. It’s free, has no side effects, and the evidence consistently shows it helps. You can buy commercial olfactory training kits or simply use essential oils. The important thing is doing it consistently, twice a day, for at least three months.
Drug Delivery and Why It Matters
One of the frustrations of sinus treatment is that medications often don’t reach where they need to go. Standard nasal sprays deposit most of their medication in the front of the nose, with poor penetration into the deeper sinus cavities where inflammation lives. Many delivery systems also end up sending a portion of the medication into the lungs rather than the sinuses.28PubMed Central. Exhalation Delivery System: Novel Device for Nasal Polyps Treatment Newer exhalation delivery systems aim to solve this by using the patient’s own breath to propel medication deeper into the nasal passages and sinuses. The mechanics are simple: you blow into a device that channels your exhaled air to carry medication into the sinuses while simultaneously closing off the soft palate so nothing goes into the lungs.
High-volume rinses partly address the delivery problem through sheer volume, which is another reason why they’re preferred over simple sprays for chronic sinusitis. If your doctor has prescribed budesonide rinses and you’re finding them ineffective, it’s worth discussing whether you’re using enough volume and the right head position. Leaning forward with your head tilted to each side for 30 seconds can make a meaningful difference in how much medication actually reaches the sinuses versus running straight through and out the other nostril.
How Doctors Measure Whether You’re Getting Better
You might hear your doctor mention the SNOT-22, which is a 22-question survey that tracks sinus-related quality of life. It sounds like a joke name, but it’s the most widely used outcome measure in chronic sinusitis research and clinical practice. The minimum change on this scale that patients can actually feel as an improvement is roughly 9 to 12 points, depending on the method used to calculate it.29PubMed. Minimal clinically important difference for the 22-item Sinonasal Outcome Test in medically managed patients with chronic rhinosinusitis When you read about studies showing a “statistically significant” improvement of, say, 5 points on the SNOT-22, that finding may be real in a mathematical sense but isn’t large enough for you to notice in daily life. Understanding this threshold helps you evaluate treatment claims more critically, whether they’re coming from a study, a new device, or a surgical technique.
The survey covers nasal symptoms like congestion and drainage, but also sleep quality, fatigue, mood, and embarrassment. Chronic sinusitis affects all of these, and effective treatment should improve more than just how your nose feels. If you’re tracking your own progress, filling out the SNOT-22 before starting a new treatment and again at three months gives you and your doctor a concrete way to tell whether something is actually working or whether you’ve just gotten used to being miserable.